Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Human OK99 Allogeneic Stem Cell Transplantation for Patients With Severe Parkinson's Disease

NCT02780895 is registered in ClinicalTrials.gov with Celavie Bioscences, LLC as lead sponsor.

NCT NCT02780895
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02780895 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Human OK99 Allogeneic Stem Cell Transplantation for Patients With Severe Parkinson's Disease
Lead sponsor
Celavie Bioscences, LLC
Phase
Phase 1
Overall status
Unknown status
Start date
May 31, 2014
Completion date
December 31, 2018
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

idiopathic parkinson disease